MCID: DBT002
MIFTS: 42

Diabetic Autonomic Neuropathy malady

Category: Neuronal diseases

Aliases & Classifications for Diabetic Autonomic Neuropathy

About this section

Aliases & Descriptions for Diabetic Autonomic Neuropathy:

Name: Diabetic Autonomic Neuropathy 11 50 13 68
 
Diabetic Neuropathies 39 68

Classifications:



External Ids:

Disease Ontology11 DOID:11503
MeSH39 D003929
SNOMED-CT62 50620007
NCIt45 C27068

Summaries for Diabetic Autonomic Neuropathy

About this section
MalaCards based summary: Diabetic Autonomic Neuropathy, also known as diabetic neuropathies, is related to diabetic neuropathy and microvascular complications of diabetes 1, and has symptoms including neuralgia and sciatica. An important gene associated with Diabetic Autonomic Neuropathy is AKR1B1 (Aldo-Keto Reductase Family 1 Member B), and among its related pathways are Differentiation Pathway and p75(NTR)-mediated signaling. The drugs capsicum oleoresin and cobalamin concentrate have been mentioned in the context of this disorder. Affiliated tissues include heart, testes and pancreatic islet, and related mouse phenotypes are muscle and normal.

Related Diseases for Diabetic Autonomic Neuropathy

About this section

Graphical network of the top 20 diseases related to Diabetic Autonomic Neuropathy:



Diseases related to diabetic autonomic neuropathy

Symptoms & Phenotypes for Diabetic Autonomic Neuropathy

About this section

UMLS symptoms related to Diabetic Autonomic Neuropathy:


neuralgia, sciatica

MGI Mouse Phenotypes related to Diabetic Autonomic Neuropathy according to GeneCards Suite gene sharing:

41
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053699.0EPO, INS, NGF, NTF3, SYNM
2MP:00028738.6DBH, EPO, INS, NGF, NTF3
3MP:00053858.2AOC1, DBH, EPO, INS, NGF, NTF3
4MP:00053767.8AKR1B1, AOC1, DBH, EPO, INS, NGF
5MP:00053867.7AKR1B1, AOC1, DBH, INS, NGF, NTF3
6MP:00053917.4AKR1B1, AOC1, DBH, INS, NGF, NTF3

Drugs & Therapeutics for Diabetic Autonomic Neuropathy

About this section

Drugs for Diabetic Autonomic Neuropathy (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 176)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Nabiloneapproved, investigationalPhase 4, Phase 31851022-71-05284592
Synonyms:
Cesamet
Nabilon
 
Nabilona
Nabilone
Nabilonum
2
Quinaprilapproved, investigationalPhase 42685441-61-854892
Synonyms:
(3S)-2-(N-{(1S)-1-[(ethyloxy)carbonyl]-3-phenylpropyl}-L-alanyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid
(3S)-2-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-3,4-dihydro-1H-isoquinoline-3-carboxylic acid
(3S)-2-{(2S)-2-[(1S)-1-ethoxycarbonyl-3-phenylpropylamino]propanoyl}-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid
(3S)-2-{N-((S)-1-Ethoxycarbonyl-3-phenylpropyl)-L-alanyl}-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid
85441-61-8
AB1004863
AC1L1HXL
AC1Q63IE
Accupril
Accuprin
Accupro
Acequin
Acuitel
BIDD:GT0797
BRD-K72222507-003-03-6
BSPBio_003022
C07398
C25H30N2O5
CHEBI:8713
CHEMBL1592
CID54892
D03752
DB00881
DivK1c_000710
Ectren
HMS2090L05
HMS502D12
IDI1_000710
KBio1_000710
 
KBio2_002077
KBio2_004645
KBio2_007213
KBio3_002522
KBioGR_000994
KBioSS_002077
Korec
Koretic
LS-177872
MolPort-003-987-265
NCGC00167962-01
NCGC00167962-02
NINDS_000710
QUINAPRIL HCL
Quinapril (USP/INN)
Quinapril Hcl
Quinapril Hydrochloride
Quinapril [INN:BAN]
Quinaprilum
Quinaprilum [Latin]
Quinazil
SPBio_000749
Spectrum2_000825
Spectrum3_001551
Spectrum4_000727
Spectrum5_001075
Spectrum_001597
TL8005458
UNII-RJ84Y44811
[3S-[2[R*(R*)],3R*]]-2-[2-[[1-(ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-1,2,3,4-tetrahydro-3-Isoquinolinecarboxylic acid
quinapril
3
Pregabalinapproved, illicit, investigationalPhase 4, Phase 3, Phase 2361148553-50-85486971
Synonyms:
(3S)-3-(aminomethyl)-5-methylhexanoic acid
(R-)-3-isobutyl GABA
(S)-3-(Aminomethyl)-5-methylhexanoic acid
(S)-3-Isobutyl gaba
(S+)-3-isobutyl GABA
121GE001
148553-50-8
3-Isobutyl gaba
3-isobutyl GABA
AC-1158
AC1NUP03
AKOS005145504
C080245
C8H17NO2
CHEBI:236161
CHEMBL1059
CI 1008
CI-1008
CID5486971
 
D02716
DB00230
FT-0080911
HSDB 7530
LS-75191
Lyrica
Lyrica (TN)
MolPort-000-861-733
PD 144723
PD-144723
Pregabalin
Pregabalin (JAN/USAN/INN)
Pregabalin [USAN]
Pregablin
S-(+)-3-isobutylgaba
S1731_Selleck
SBB062901
TL8001062
TOS-BB-0910
UNII-55JG375S6M
4
Lidocaineapproved, vet_approvedPhase 41317137-58-63676
Synonyms:
.alpha.-(Diethylamino)-2,6-acetoxylidide
.alpha.-Diethylamino-2,6-dimethylacetanilide
.alpha.-Diethylaminoaceto-2,6-xylidide
.omega.-Diethylamino-2,6-dimethylacetanilide
137-58-6
2-(Diethylamino)-2',6'-acetoxylidide
2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide
2-Diethylamino-N-(2,6-dimethyl-phenyl)-acetamide
2-Diethylamino-N-(2,6-dimethylphenyl)acetamide
4-12-00-02538 (Beilstein Handbook Reference)
6108-05-0 (MONOHYDROCHLORIDE MONOHYDRATE))
6108-05-0 (mono-hydrochloride, mono-hydrate)
73-78-9 (mono-hydrochloride)
AB00053581
AC-10282
AC1L1GGQ
AC1Q2Z7J
AKOS001026768
ARONIS23855
After Burn Double Strength Gel
After Burn Double Strength Spray
After Burn Gel
After Burn Spray
Alphacaine
Anestacon
Anestacon Jelly
BIDD:GT0342
BPBio1_000197
BRD-K52662033-001-02-6
BRD-K52662033-003-05-5
BRN 2215784
BSPBio_000179
BSPBio_001359
BSPBio_003004
Bio-0767
Bio1_000379
Bio1_000868
Bio1_001357
Bio2_000079
Bio2_000559
C07073
C14H22N2O
CAS-73-78-9
CDS1_000283
CHEBI:6456
CHEMBL79
CID3676
CPD000058189
Cappicaine
Cito optadren
Cuivasil
D00358
DB00281
Dalcaine
Dentipatch
Dentipatch (TN)
DermaFlex
Diethylaminoaceto-2,6-xylidide
Dilocaine
DivK1c_000174
DivK1c_001323
Duncaine
EINECS 205-302-8
ELA-Max
EMBOLEX
Emla
Emla Cream
Esracaine
FT-0082378
Gravocain
HMS1791D21
HMS1989D21
HMS2051C21
HMS2089E15
HMS548M19
HSDB 3350
I01-2704
IDI1_000174
IDI1_033829
Isicaina
Isicaine
Jetocaine
KBio1_000174
KBio2_000079
KBio2_001598
KBio2_002647
KBio2_004166
KBio2_005215
KBio2_006734
KBio3_000157
KBio3_000158
KBio3_002224
KBioGR_000079
KBioGR_000599
KBioSS_000079
KBioSS_001598
L-Caine
L0156
L1026_SIGMA
L7757_SIGMA
LIDOCAINE (73-58-6 (MONOHYDROCHLORIDE)
LIDOPEN
LQZ
 
LS-805
Lanabiotic
Leostesin
Lida-Mantle
Lidocaina
Lidocaina [INN-Spanish]
Lidocaine (JP15/USP/INN)
Lidocaine (VAN)
Lidocaine Carbonate
Lidocaine Hydrocarbonate
Lidocaine Monohydrochloride
Lidocaine [USAN:INN:JAN]
Lidocainum
Lidocainum [INN-Latin]
Lidocaton
Lidoderm
Lidoject-1
Lidoject-2
Lignocaine
Lignocainum
Lingocaine
Lopac-L-5647
Lopac0_000669
MLS000069724
MLS000758263
MLS001074177
Maricaine
Maybridge1_002571
MolPort-001-783-478
N-(2,6-dimethylphenyl)-N(2),N(2)-diethylglycinamide
N-(2,6-dimethylphenyl)-N~2~,N~2~-diethylglycinamide
NCGC00015611-01
NCGC00015611-02
NCGC00015611-03
NCGC00015611-04
NCGC00015611-14
NCGC00022176-05
NCGC00022176-06
NCGC00022176-07
NCGC00022176-08
NCGC00022176-09
NINDS_000174
NSC 40030
NSC40030
Norwood Sunburn Spray
Octocaine
Octocaine-100
Octocaine-50
Prestwick0_000050
Prestwick1_000050
Prestwick2_000050
Prestwick3_000050
Remicaine
Rocephin Kit
Rucaina
S1357_Selleck
SAM001247018
SMR000058189
SPBio_001525
SPBio_002100
STK552033
Solarcaine
Solarcaine aloe extra burn relief cream
Solcain
Spectrum2_001343
Spectrum3_001392
Spectrum4_000070
Spectrum5_001549
Spectrum_001118
UNII-98PI200987
WLN: 2N2 & 1VMR B1 F1
Xilina
Xilocaina
Xilocaina [Italian]
Xllina
Xycaine
Xylestesin
Xylesthesin
Xylocain
Xylocaine
Xylocaine (TN)
Xylocaine 5% Spinal
Xylocaine CO2
Xylocaine Dental Ointment
Xylocaine Endotracheal
Xylocaine Test Dose
Xylocaine Viscous
Xylocaine-MPF
Xylocaine-MPF with Glucose
Xylocaine-Mpf
Xylocaine-Mpf with Glucose
Xylocard
Xylocitin
Xyloneural (free base)
Xylotox
Zilactin-L
Zingo
alfa-Dietilamino-2,6-dimetilacetanilide
alfa-Dietilamino-2,6-dimetilacetanilide [Italian]
alpha-Diethylamino-2,6-dimethylacetanilide
alpha-diethylamino-2,6-dimethylacetanilide
lidocaine
nchembio.65-comp16
α-diethylamino-2,6-dimethylacetanilide
5
Gabapentinapproved, investigationalPhase 430360142-96-33446
Synonyms:
1-(Aminomethyl)-cyclohexaneacetic acid
1-(Aminomethyl)cyclohexaneacetic acid
2-[1-(aminomethyl)cyclohexyl]acetic acid
60142-96-3
AC-1485
AC1L1FYE
AC1Q53PH
AKOS000280865
Aclonium
Apo-Gabapentin
Apotex brand of gabapentin
Aventis brand of gabapentin
BB_SC-1512
BIDD:GT0656
BPBio1_000993
BRN 2359739
BSPBio_000901
C040029
C9H17NO2
CAS-60142-96-3
CCRIS 7210
CHEBI:188316
CHEBI:42797
CHEMBL940
CI 945
CI-945
CID3446
D00332
DB00996
DDS-2003
DM-1796
DM-5689
EINECS 262-076-3
EU-0100582
G-154
G0318
G154_SIGMA
GBN
GOE 2450
Gabapen
Gabapentin
Gabapentin (JAN/USAN/INN)
Gabapentin GR
Gabapentin Hexal
Gabapentin Stada
Gabapentin [USAN:INN:BAN]
Gabapentin-ratiopharm
Gabapentina
Gabapentine
Gabapentine [INN-French]
Gabapentino
Gabapentino [INN-Spanish]
Gabapentino [Spanish]
Gabapentinum
 
Gabapentinum [INN-Latin]
Gabapetin
Go 3450
Goe-3450
HMS1570N03
HMS2089J03
HSDB 7364
Hexal brand of gabapentin
I06-0677
L000733
LS-7194
Lopac-G-154
Lopac0_000582
MLS000069358
MolPort-000-883-862
NCGC00015466-01
NCGC00015466-02
NCGC00015466-06
NCGC00015466-09
NCGC00016891-01
NCGC00021545-02
NCGC00021545-04
NCGC00021545-05
NSC742194
Neurontin
Neurontin (TN)
Novo-Gabapentin
Novo-Gabapentine
Novopharm brand of gabapentin
PMS-Gabapentin
Parke Davis brand of gabapentin
Pfizer brand of gabapentin
Pharmascience brand of gabapentin
Prestwick0_000861
Prestwick1_000861
Prestwick2_000861
Prestwick3_000861
Prestwick_151
S2133_Selleck
SMR000058311
SPBio_002822
STK598009
Serada
Stadapharm brand of gabapentin
TL8003814
Tocris-0806
UNII-6CW7F3G59X
Vultin
Warner-Lambert brand of gabapentin
[1-(AMINOMETHYL)CYCLOHEXYL]ACETIC ACID
gabapentin
gabapentin (Neurontin)
gabapentina
gabapentinium
ratiopharm brand of gabapentin
6
CilostazolapprovedPhase 410673963-72-12754
Synonyms:
3,4-Dihydro-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-2(1H)-quinolinone
3,4-dihydro-6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-2(1H)-quinolinone
6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydro-2(1H)-quinolinone
6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydrocarbostyril
6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxyl)-3,4-dihydrocarobostyril
6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)-butoxy]-3,4-dihydro-1H-quinolin-2-one
6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)-butoxy]-3,4-dihydro-2(1H)-quinolinone
6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydroquinolin-2(1H)-one
6-[4-(1-cyclohexyltetrazol-5-yl)butoxy]-3,4-dihydro-1H-quinolin-2-one
73963-72-1
89332-50-3
AC-4334
AC1L1EE2
BRD-K67017579-001-04-2
BRD-K67017579-001-05-9
BRD-K67017579-001-07-5
BRD-K67017579-001-13-3
BRN 3632107
BSPBio_002759
C 0737
C045645
C0737_SIGMA
C20H27N5O2
CHEBI:31401
CHEMBL799
CID2754
CL23867
CPD000058428
Cilostazol (JP15/USAN/INN)
Cilostazol [INN:JAN]
Cilostazole
Cilostazolum
Cilostazolum [INN-Latin]
D01896
DB01166
EU-0100218
HMS1922N15
HMS2093M14
KBio3_002259
KBioGR_001184
 
LS-142693
Lopac-C-0737
Lopac0_000218
MLS000028470
MLS000758281
MLS000759507
MLS001076067
MLS002153891
MolPort-001-758-007
NCGC00015207-01
NCGC00015207-02
NCGC00015207-06
NCGC00015207-10
NCGC00022153-02
NCGC00022153-04
NCGC00022153-05
NCGC00022153-06
NCGC00022153-07
OPC 13013
OPC 21
OPC-13013
OPC-21
Otsuka brand of cilostazol
Pletaal
Pletal
Pletal (TN)
Pletal, Cilostazol
S1294_Selleck
SAM001246734
SAM001247085
SMR000058428
SPBio_001256
SPECTRUM1505230
Spectrum2_001118
Spectrum3_001170
Spectrum4_000772
Spectrum5_001762
TL8005113
Tocris-1692
UNII-N7Z035406B
ZINC01552174
cilostazol
7
DopamineapprovedPhase 4, Phase 2383651-61-6, 62-31-7681
Synonyms:
(3H)-Dopamine
.Beta.-(3,4-Dihydroxyphenyl)ethylamine hydrochloride
.alpha.-(3,4-Dihydroxyphenyl)-.beta.-aminoethane
1,2-Benzenediol, 4-(2-aminoethyl)- (9CI)
1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride
1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium
153C5321-5FEE-4B0B-8925-F388F0EEEBD1
2-(3,4-Dihydroxyphenyl)ethylamine
2-(3,4-dihydroxyphenyl)ethylamine
2-benzenediol
3,4-Dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine hydrochloride
3,4-Dihydroxyphenylethylamine
3,4-dihydroxyphenethylamine
3-Hydroxtyramine
3-Hydroxytyramine
3-Hydroxytyramine Hydrobromide
3-Hydroxytyramine hydrochloride
4-(2-Aminoethyl)-1,
4-(2-Aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)-1,2-bezenediol
4-(2-Aminoethyl)-Pyrocatechol
4-(2-Aminoethyl)benzene-1,2-diol
4-(2-Aminoethyl)catechol
4-(2-Aminoethyl)pyrocatechol
4-(2-Aminoethyl)pyrocatechol hydrochloride
4-(2-aminoethyl)-pyrocatechol
50444-17-2
51-61-6
62-31-7 (HYDROCHLORIDE)
AC1L19S5
AC1Q54AX
AC1Q54AY
AKOS003790978
ASL 279
BIDD:ER0506
BPBio1_001123
BSPBio_001932
Biomol-NT_000001
C03758
CHEBI:18243
CHEMBL59
CID681
D07870
DB00988
Deoxyepinephrine
DivK1c_000780
Dopamin
Dopamina
Dopamina [INN-Spanish]
Dopamine
Dopamine (INN)
Dopamine (USAN)(*hydrochloride*)
Dopamine [INN:BAN]
Dopaminum
Dopaminum [INN-Latin]
Dopastat
Dophamine
Dynatra
EINECS 200-110-0
HSDB 3068
Hydroxytyramin
Hydroxytyramine
IDI1_000780
IP 498
Intropin
Intropin [*hydrochloride*]
KBio1_000780
 
KBio2_001492
KBio2_002388
KBio2_002484
KBio2_004060
KBio2_004956
KBio2_005052
KBio2_006628
KBio2_007524
KBio2_007620
KBio3_001152
KBio3_002867
KBio3_002962
KBioGR_001129
KBioGR_002388
KBioGR_002484
KBioSS_001492
KBioSS_002393
KBioSS_002491
KW-3-060
L-DOPAMINE
L000232
LDP
LS-159
Lopac-H-8502
Lopac0_000586
Medopa (TN)
MolPort-001-641-000
NCGC00015519-01
NCGC00015519-08
NCGC00096050-01
NCGC00096050-02
NCGC00096050-03
NCGC00096050-04
NCGC00096050-05
NINDS_000780
NSC 173182
NSC169105
NSC173182
Oprea1_088821
Oxytyramine
Pyrocatechol, 4-(2-aminoethyl)- (8CI)
Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride
Revimine
Revivan
SPBio_001205
SPECTRUM1505155
ST048774
STK301601
Spectrum2_001023
Spectrum3_000406
Spectrum4_000525
Spectrum5_000945
Spectrum_001012
UNII-VTD58H1Z2X
UPCMLD0ENAT5885989:001
a-(3,4-Dihydroxyphenyl)-b-aminoethane
alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane
cMAP_000036
cMAP_000065
dopamine
hydroxytyramine
intropin
m-Hydroxytyramine hydrochloride
nchembio.105-comp9
nchembio.107-comp4
nchembio.284-comp1
nchembio.78-comp16
nchembio.89-comp3
nchembio705-8
nchembio801-comp8
8
Bromocriptineapproved, investigationalPhase 43125614-03-331101
Synonyms:
(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman
(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione
(5'alpha)-2-bromo-12'-hydroxy-5'-(2-methylpropyl)-2'-(propan-2-yl)-3',6',18-trioxoergotaman
(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman
(6aR,9R)-5-Bromo-N-((2R,5S,10aS,10bS)-10b-hydroxy-5-isobutyl-2-isopropyl-3,6-dioxooctahydro-2H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl)-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide
2-Bromo-12'-hydroxy-2'-(1-methylethyl)-5'-alpha-(2-methylpropyl)ergotamin-3',6',18-trione
2-Bromo-alpha-ergocryptine
2-Bromo-alpha-ergokryptin
2-Bromo-alpha-ergokryptine
2-Bromoergocryptine Methanesulfonate
2-Bromoergokryptine
2-bromo-α-ergocryptine
2-bromo-α-ergokryptin
2-bromo-α-ergokryptine
22260-51-1 (mesylate (salt))
25614-03-3
AC-13601
AC1L1KXS
AC1Q2716
Alti-Bromocriptine
Apo-Bromocriptine
BIDD:GT0464
BPBio1_001131
BRD-K14496212-001-01-1
Bagren
Biomol-NT_000005
Bromergocryptine
Bromocriptin
Bromocriptina
Bromocriptina [INN-Spanish]
Bromocriptine (USAN/INN)
Bromocriptine Methanesulfonate
Bromocriptine [BAN]
Bromocriptine [USAN:BAN:INN]
 
Bromocriptine methanesulfonate
Bromocriptinum
Bromocriptinum [INN-Latin]
Bromocryptin
Bromocryptine
Bromoergocriptine
Bromoergocryptine
C06856
C32H40BrN5O5
CB-154
CCRIS 3244
CHEBI:3181
CHEMBL493
CID31101
D03165
DB01200
EINECS 247-128-5
Ergocryptine, 2-bromo- (8CI)
Ergoset
LS-64540
Lopac0_000171
MolPort-002-512-064
NCGC00024584-04
NCI60_001365
NSC169774
PDSP2_001500
Parlodel
Parlodel Snaptabs
Prestwick0_000121
Prestwick1_000121
Prestwick2_000121
SPBio_002101
UNII-3A64E3G5ZO
bromocriptine
nchembio873-comp18
9
Prednisoloneapproved, vet_approvedPhase 4119350-24-85755
Synonyms:
(11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione
.DELTA.1-Cortisol
.DELTA.1-Dehydrocortisol
.DELTA.1-Dehydrohydrocortisone
.DELTA.1-Hydrocortisone
.delta.-Cortef
.delta.-Stab
1,2-Dehydrohydrocortisone
1,4-Pregnadiene-11beta,17alpha,21-triol-3,20-dione
1,4-Pregnadiene-3,20-dione-11beta,17alpha,21-triol
1-Dehydrocortisol
1-Dehydrohydrocortisone
3,20-dioxo-11beta,17alpha,21-Trihydroxy-1,4-pregnadiene
46656_FLUKA
46656_RIEDEL
50-24-8
58201-11-9
8056-11-9
AC-1773
AC1L1L2E
Ak-Pred
Ak-Tate
Alphadrol
Articulose-50
BPBio1_000164
BRD-K98039984-001-03-0
BRN 1354103
BSPBio_000148
Bio-0666
Bubbli-Pred
C07369
CCRIS 980
CHEBI:8378
CHEMBL131
CID5755
CO-Hydeltra
CPD000718761
Co-Hydeltra
Codelcortone
Cordrol
Cortalone
Cotogesic
Cotolone
D00472
D011239
DB00860
Decaprednil
Decortin H
Delcortol
Delta F
Delta(1)-dehydrohydrocortisone
Delta-Cortef
Delta-Cortef (TN)
Delta-Ef-Cortelan
Delta-Stab
Delta-stab
Deltacortenol
Deltacortril
Deltacortril Enteric
Deltahydrocortisone
Deltasolone
Deltisilone
Depo-Medrol
Derpo PD
Derpo Pd
Dexa-Cortidelt Hostacortin H
Dexa-Cortidelt hostacortin H
Di Adreson F
Di-Adreson F
Di-Adreson-F
Di-adreson F
DiAdresonF
Dicortol
Donisolone
Dydeltrone
EINECS 200-021-7
Eazolin D
Econopred
Econopred Plus
Erbacort
Erbasona
Estilsona
Fernisolone
Fernisolone P
Fernisolone-P
Flamasone
HMS1568H10
HMS2090J05
HSDB 3385
Hostacortin H
Hydeltra
Hydeltra-Tba
Hydeltrasol
Hydeltrone
Hydrodeltalone
Hydrodeltisone
Hydroretrocortin
Hydroretrocortine
I-Pred
Inflamase Forte
Inflamase Mild
K 1557
Key-Pred
Klismacort
LMST02030179
LS-7669
Lentosone
Lite Pred
M-Predrol
 
MLS001304083
MLS002154250
MLS002207037
Medrol
Medrol Acetate
Metacortandralone
Methylprednisolone Acetate
Meti-Derm
Meticortelone
Metreton
MolPort-002-507-147
NCGC00179649-01
NSC 9120
NSC9120
NSC9900
Neo-Delta-Cortef
Nisolone
Nor-Pred T.B.A.
Ocu-Pred
Ocu-Pred Forte
Ophtho-Tate
Orapred
P0152_SIGMA
P0637
P6004_SIGMA
PRDL
PRED-G
Panafcortelone
Paracortol
Paracotol
Pediapred
Poly-Pred
Precortalon
Precortancyl
Precortilon
Precortisyl
Pred Forte
Pred Mild
Predair
Predair A
Predair Forte
Predalone 50
Predalone T.B.A.
Predate
Predate Tba
Predate-50
Predcor-25
Predcor-50
Predcor-Tba
Predisolone Sodium Phosphate
Predne-Dome
Prednelan
Predni-Dome
Prednicen
Predniliderm
Predniretard
Prednis
Prednisolona
Prednisolona [INN-Spanish]
Prednisolone (JP15/USP/INN)
Prednisolone (anhydrous)
Prednisolone Acetate
Prednisolone Sodium Phosphate
Prednisolone Tebutate
Prednisolone [INN:BAN:JAN]
Prednisolonum
Prednisolonum [INN-Latin]
Predonin
Predonine
Prelone
Prenolone
Prestwick0_000274
Prestwick1_000274
Prestwick2_000274
Prestwick3_000274
Prestwick_404
Rolisone
S1737_Selleck
SAM002264639
SMR000718761
SPBio_002367
Scherisolon
Solone
Steran
Sterane
Sterolone
Supercortisol
UNII-9PHQ9Y1OLM
Ulacort
Ultra Pred
Ultracorten H
Ultracortene H
Ultracortene-H
Ultracortene-Hydrogen
Ultracortene-hydrogen
ZINC03833821
component of Ataraxoid
component of K-Predne-Dome
delta(1)-Cortisol
delta(1)-Dehydrocortisol
delta(1)-Dehydrohydrocortisone
delta(1)-Hydrocortisone
delta(sup 1)-Cortisol
delta(sup 1)-Dehydrocortisol
delta(sup 1)-Dehydrohydrocortisone
delta(sup 1)-Hydrocortisone
delta-dehydrocortisol
delta-dehydrohydrocortisone
delta-hydrocortisone
prednisolone
10
Methylprednisoloneapproved, vet_approvedPhase 4119383-43-26741
Synonyms:
(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
(6a,11b)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6α,11β)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione
.DELTA.1-6.alpha.-Methylhydrocortisone
1-Dehydro-6alpha-methylhydrocortisone
1-dehydro-6alpha-Methylhydrocortisone
1-dehydro-6α-methylhydrocortisone
11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione
11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methyl-1,4-pregnadiene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
121673-01-6
4-08-00-03498 (Beilstein Handbook Reference)
46436_FLUKA
46436_RIEDEL
570-35-4
6 Methylprednisolone
6-Methylprednisolone
6-alpha-Methylprednisolone
6.alpha.-Methylprednisolone
6923-42-8
6alpha-Methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione
6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
6alpha-Methylprednisolone
6alpha-methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
83-43-2
AC1L1N7A
Artisone-Wyeth
Artisone-wyeth
BPBio1_000174
BRD-K35240538-001-03-1
BRN 2340300
BSPBio_000158
Besonia
Bio-0658
CHEBI:6888
CHEMBL650
CID6741
CPD000058330
D00407
D008775
DB00959
Depo-Medrol (acetate)
Dopomedrol
EINECS 201-476-4
Esametone
Firmacort
HMS1568H20
HMS2090B13
HSDB 3127
LMST02030178
LS-118498
Lemod
M0639_SIGMA
M1665
MEPRDL
MLS000028541
MLS001148159
MLS002207191
Medesone
Medixon
Medlone 21
 
Medrate
Medrol
Medrol (TN)
Medrol Adt Pak
Medrol Dosepak
Medrol adt pak
Medrol dosepak
Medrol, Solu-Medrol, Medrone, Methylprednisolone
Medrone
Mesopren
Metastab
Methyleneprednisolone
Methylprednisolon
Methylprednisolone
Methylprednisolone (JP15/USP/INN)
Methylprednisolone [USAN:INN:BAN:JAN]
Methylprednisolone, 6-alpha
Methylprednisolonum
Methylprednisolonum [INN-Latin]
Metilbetasone
Metilprednisolona
Metilprednisolona [INN-Spanish]
Metilprednisolone
Metilprednisolone [DCIT]
Metilprednisolone [Dcit]
Metipred
Metrisone
Metrocort
Metysolon
Moderin
MolPort-002-528-554
NCGC00022735-03
NCI60_001657
NSC-19987
NSC19987
Nirypan
Noretona
Predni N Tablinen
Prednol- L
Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl- (8CI)
Prestwick0_000279
Prestwick1_000279
Prestwick2_000279
Prestwick3_000279
Prestwick_622
Promacortine
Reactenol
S1733_Selleck
SAM002589984
SMR000058330
SPBio_002377
Sieropresol
Solomet
Summicort
Suprametil
U 7532
UNII-X4W7ZR7023
Urbason
Urbasone
Wyacort
ZINC03875560
delta(1)-6alpha-Methylhydrocortisone
delta(sup 1)-6-alpha-Methylhydrocortisone
methylprednisolone
methylprenisolone
11Fibrinolytic AgentsPhase 4, Phase 12388
12Excitatory Amino AcidsPhase 4, Phase 31362
13Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 4, Phase 3, Phase 213168
14Neurotransmitter AgentsPhase 4, Phase 3, Phase 2, Phase 118340
15AnestheticsPhase 4, Phase 3, Phase 29596
16Hormone AntagonistsPhase 4, Phase 3, Phase 213180
17Respiratory System AgentsPhase 4, Phase 3, Phase 2, Phase 14997
18HormonesPhase 4, Phase 3, Phase 214415
19Gastrointestinal AgentsPhase 4, Phase 3, Phase 28402
20AnticonvulsantsPhase 4, Phase 3, Phase 22695
21Excitatory Amino Acid AntagonistsPhase 4, Phase 31347
22HIV Protease InhibitorsPhase 4, Phase 25470
23Anti-Anxiety AgentsPhase 4, Phase 3, Phase 21885
24
protease inhibitorsPhase 4, Phase 25471
Synonyms:
 
protease inhibitors
25AnalgesicsPhase 4, Phase 3, Phase 211733
26Central Nervous System DepressantsPhase 4, Phase 3, Phase 213403
27Peripheral Nervous System AgentsPhase 4, Phase 3, Phase 2, Phase 123689
28Autonomic AgentsPhase 4, Phase 3, Phase 2, Phase 110150
29Antihypertensive AgentsPhase 4, Phase 3, Phase 24207
30AntiemeticsPhase 4, Phase 3, Phase 24022
31Tranquilizing AgentsPhase 4, Phase 3, Phase 24265
32Psychotropic DrugsPhase 4, Phase 3, Phase 26430
33
gamma-Aminobutyric AcidPhase 424156-12-2119
Synonyms:
3-Carboxypropylamine
4-Aminobutanoate
4-Aminobutanoic acid
4-Aminobutyrate
4-Aminobutyric acid
Aminalon
GABA
Gaballon
Gamarex
Gammalon
Gammalone
Gammar
Gammasol
 
Mielogen
Mielomade
Omega-Aminobutyrate
Omega-Aminobutyric acid
Piperidate
Piperidic acid
Piperidinate
Piperidinic acid
gamma Aminobutyrate
gamma Aminobutyric acid
gamma-Aminobutyrate
gamma-Aminobutyric acid
w-Aminobutyrate
w-Aminobutyric acid
34Angiotensin-Converting Enzyme InhibitorsPhase 4724
35Anti-Inflammatory AgentsPhase 4, Phase 310729
36Sodium Channel BlockersPhase 41593
37GABA AgentsPhase 41684
38Neuroprotective AgentsPhase 41716
39Phosphodiesterase 3 InhibitorsPhase 4133
40Phosphodiesterase InhibitorsPhase 4, Phase 21289
41Bronchodilator AgentsPhase 4, Phase 3, Phase 2, Phase 12965
42Anti-Asthmatic AgentsPhase 4, Phase 3, Phase 2, Phase 13488
43calcium channel blockersPhase 4, Phase 3, Phase 21985
44Diuretics, Potassium SparingPhase 41917
45Platelet Aggregation InhibitorsPhase 42516
46Calcium, DietaryPhase 4, Phase 3, Phase 25713
47Anti-Arrhythmia AgentsPhase 43093
48Antimanic AgentsPhase 4814
49Anesthetics, LocalPhase 4, Phase 23492
50Antiparkinson AgentsPhase 41574

Interventional clinical trials:

(show top 50)    (show all 79)
idNameStatusNCT IDPhase
1Inspiratory Muscle Training in Patients With Autonomic NeuropathicUnknown statusNCT00752440Phase 4
2Bi-Axial Rotating Magnetic Field Therapy in Refractory Neuropathic Foot Pain Secondary to Diabetic Peripheral NeuropathyUnknown statusNCT00123136Phase 4
3Efficacy of Administration of ACE-Inhibition on Autonomic and Peripheral Neuropathy in Patients With Diabetes MellitusCompletedNCT03031834Phase 4
4Autonomic Nervous System Dysfunction and Peripheral Neuropathy in a Cohort of Asymptomatic Juvenile Diabetic Patients (Type I): A Case-Controlled StudyCompletedNCT00466778Phase 4
5A Randomized Double-Blind Study Testing the Effects of Pregabalin on Diabetic NeuropathyCompletedNCT00573261Phase 4
6Evaluation of the Efficacy of Cesamet™ for the Treatment of Pain in Patients With Diabetic Peripheral NeuropathyCompletedNCT00380913Phase 4
7Asian Study on Cilostazol Effectivity in Neuropathies of Diabetes Mellitus Type 2-A Pilot Study in the PhilippinesCompletedNCT01076478Phase 4
8A Study Of Lidocaine Patch 5% Alone, Gabapentin Alone, And Lidocaine Patch 5% And Gabapentin In Combination For The Relief Of Pain In Patients With Diverse Peripheral Neuropathic Pain ConditionsCompletedNCT00904202Phase 4
9Bromocriptine-QR Therapy on Sympathetic Tone and Vascular Biology in Type 2 Diabetes SubjectsRecruitingNCT02682901Phase 4
10Combined Radiotherapy and Intravenous Steroids for Early Progressive Thyroid Eye DiseaseNot yet recruitingNCT02339142Phase 4
11Efficacy Study of Nabilone in the Treatment of Diabetic Peripheral Neuropathic PainUnknown statusNCT01035281Phase 3
12Diabetic Neuropathy Topical TreatmentUnknown statusNCT00661063Phase 3
13An Intervention Trial for Cardiac Neuropathy in Type 1 DiabetesCompletedNCT00116207Phase 3
14Anti-Nephropathic Effects of Chronic Intermittent Intravenous Insulin Therapy (CIIIT)CompletedNCT00594152Phase 3
15Fluid Retention in Rosiglitazone Treated Subjects With Autonomic Neuropathy.CompletedNCT00422955Phase 3
16Efficacy and Safety Study of Pregabalin in the Treatment of Pain on Walking in Patients With Diabetic Peripheral Neuropathy (DPN)CompletedNCT01474772Phase 3
17Effect Of Pregabalin Treatment In Patients With Diabetic Nerve Pain Who Currently Use A Non-Steroid Anti-Inflammatory Drug (NSAID) For Another PainCompletedNCT01455415Phase 3
18Safety and Efficacy Study of Fx-1006A in Patients With Familial AmyloidosisCompletedNCT00409175Phase 2, Phase 3
19Clinical Trial for the Treatment of Diabetic Foot Ulcers Using a Nitric Oxide Releasing Patch: PATHONCompletedNCT00428727Phase 3
20Muscarinic Receptor Antagonists as a Therapy for Diabetic NeuropathyRecruitingNCT03050827Phase 3
21The Study of an Investigational Drug, Patisiran (ALN-TTR02), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis in Patients Who Have Already Been Treated With ALN-TTR02 (Patisiran)Enrolling by invitationNCT02510261Phase 3
22Acetylcholinesterase Inhibition and Orthostatic Hypotension in SC IUnknown statusNCT02307526Phase 2
23Effect of Autonomic Neuropathy on the Efficacy of a DPP-IV Inhibitor (Galvus) TherapyCompletedNCT01452113Phase 2
24Efficacy and Safety of TAK-583 in Subjects With Diabetic Peripheral NeuropathyCompletedNCT00760955Phase 2
25A Multicenter Study Comparing the Analgesic Effects and Safety of ABT-639 Compared to Placebo in Subjects With Diabetic Neuropathic PainCompletedNCT01345045Phase 2
26Effects of Reiki on Painful Neuropathy and Cardiovascular Risk FactorsCompletedNCT00010751Phase 2
27Efficacy and Safety Study of ARC-4558 for Management of Pain Associated With Painful Diabetic NeuropathyCompletedNCT00695565Phase 2
28Safety and Efficacy Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic NeuropathyCompletedNCT02068027Phase 2
29A Safety Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Painful Diabetic NeuropathyCompletedNCT02355158Phase 2
30The Efficacy and Safety of Clonidine Hydrochloride Topical Gel, vs Clonidine Hydrochloride Gel Comparator to Treat Painful Diabetic NeuropathyCompletedNCT02643251Phase 2
31A Study on the Safety and Efficacy of Nitric Oxide Gel in Subjects With Painful Diabetic NeuropathyCompletedNCT01633086Phase 2
32Effects of Moxaverine and Placebo on Ocular Blood FlowCompletedNCT00709423Phase 2
33Nitric Oxide Generating Gel Dressing in Patients With Diabetic Foot UlcersCompletedNCT01982565Phase 1, Phase 2
34Improving Autonomic Function and Balance in Diabetic NeuropathyRecruitingNCT01864460Phase 2
35Evaluation of Diagnostic Methods and Dietary Treatment of Diabetic GastroparesisRecruitingNCT01557296Phase 2
36The Efficacy Of Intravenous Immunoglobulin Therapy In Treatment Induced Neuropathy Of DiabetesNot yet recruitingNCT02915263Phase 2
37A Study of Effectiveness and Safety of JNJ-42160443 in Patients With Diabetic Painful NeuropathyTerminatedNCT00993018Phase 2
38Safety and Preliminary Efficacy Study of Nicotine Gel to Treat Diabetic Foot UlcersTerminatedNCT00316537Phase 1, Phase 2
39A Study of Single Dose Pain Therapy in Patients With Painful Diabetic Neuropathy (0000-115)WithdrawnNCT00837941Phase 2
40Effect of Local Application of Boron on Diabetic Foot UlcersUnknown statusNCT02087215Phase 1
41A Comparison Between Pupillometry, Heart Rate Variability and Metaiodobenzylguanidine Scintigraphy for the Diagnosis of Early Diabetic Autonomic Neuropathy in Type 1 DiabetesUnknown statusNCT01822431
42The Relationship Between Vascular Adhesion Protein-1 and Diabetic Cardiovascular Autonomic NeuropathyUnknown statusNCT01706289
43Sleep Apnea in Type 1 DiabetesUnknown statusNCT01935765Early Phase 1
44Effect of DPP-IV Inhibitor on Glycemic Control and Autonomic Neuropathy in Adult Patients With Diabetes MellitusUnknown statusNCT01545024
45Changes in Skin Innervation of Neurologically Asymptomatic Type 2 Diabetic Patients: the Correlation With the Diabetic Parameters and Neurotrophins.Unknown statusNCT00155142
46The Relative Prevalence and Severity of Autonomic Nervous System DysfunctionCompletedNCT00919347
47Coronary Blood Flow Regulation During General AnesthesiaCompletedNCT00866801
48NIR- and Multifrequent Impedance Spectroscopy on the Skin in Type 1 DiabetesCompletedNCT01707979
49Pyridostigmine and Its Effects on Autonomic Modulation in Diabetic PatientsCompletedNCT00953914
50Evaluation of Exenatide in Patients With Diabetic NeuropathyCompletedNCT00855439

Search NIH Clinical Center for Diabetic Autonomic Neuropathy

Inferred drug relations via UMLS68/NDF-RT46:


Cochrane evidence based reviews: diabetic neuropathies

Genetic Tests for Diabetic Autonomic Neuropathy

About this section

Anatomical Context for Diabetic Autonomic Neuropathy

About this section

MalaCards organs/tissues related to Diabetic Autonomic Neuropathy:

36
Heart, Testes, Pancreatic islet, Skin, Eye, Brain

Publications for Diabetic Autonomic Neuropathy

About this section

Articles related to Diabetic Autonomic Neuropathy:

(show top 50)    (show all 289)
idTitleAuthorsYear
1
Inspiratory muscle training in patients with diabetic autonomic neuropathy: a randomized clinical trial. (25982993)
2015
2
Role of Microcirculatory Disturbances and Diabetic Autonomic Neuropathy in Takotsubo Cardiomyopathy. (26468716)
2015
3
Morphologic Changes in Autonomic Nerves in Diabetic Autonomic Neuropathy. (26706915)
2015
4
Association of diabetic autonomic neuropathy with red blood cell aldose reductase activity. (24485209)
2014
5
CORNEAL confocal microscopy for the diagnosis of diabetic autonomic neuropathy. (25556884)
2014
6
Disproportionate pupillary involvement in diabetic autonomic neuropathy. (25377131)
2014
7
Diabetic autonomic neuropathy. (25410215)
2014
8
Diabetic autonomic neuropathy affects symptom generation and brain-gut axis. (24026548)
2013
9
Diabetic autonomic neuropathy. (24095132)
2013
10
Highlights in clinical autonomic neuroscience: latest developments in the early detection of diabetic autonomic neuropathy. (22306250)
2012
11
Mortality after acute myocardial infarction: significance of cardiovascular diabetic autonomic neuropathy (CDAN). (23097964)
2012
12
Diabetic autonomic neuropathy. (23393679)
2012
13
The effect of diabetic autonomic neuropathy on P-wave duration, dispersion and atrial fibrillation. (22291825)
2011
14
The relationship between diabetic autonomic neuropathy and diabetic risk factors in a Taiwanese population. (21986117)
2011
15
Vasopressin release induced by hypothension is blunted in patients with diabetic autonomic neuropathy. (20370555)
2011
16
Severe orthostatic hypotension in a diabetic patient may not be due to diabetic autonomic neuropathy. (21902089)
2011
17
Recommendations for the use of cardiovascular tests in diagnosing diabetic autonomic neuropathy. (21247746)
2011
18
Gastric mucosal nerve density: a biomarker for diabetic autonomic neuropathy? (20837965)
2010
19
Different effects of diabetic autonomic neuropathy on regional transcutaneous oxygen tension in patients with peripheral arterial disease. (21466127)
2010
20
Effect of acute hyperglycaemia on sensory processing in diabetic autonomic neuropathy. (20624170)
2010
21
Cough reflex sensitivity in adolescents with diabetic autonomic neuropathy. (20156724)
2009
22
A pharmacologic pupillary test in the diagnosis of diabetic autonomic neuropathy. (20046691)
2009
23
New insights in diabetic autonomic neuropathy in children and adolescents. (19734243)
2009
24
The impact of diabetic autonomic neuropathy on the incretin effect. (18376350)
2008
25
Dynamic cerebral autoregulation assessment using chaotic analysis in diabetic autonomic neuropathy. (17874153)
2008
26
Erythropoietin and its carbamylated derivative prevent the development of experimental diabetic autonomic neuropathy in STZ-induced diabetic NOD-SCID mice. (17967455)
2008
27
Gut sensations in diabetic autonomic neuropathy. (17521809)
2007
28
Ergotamine use in severe diabetic autonomic neuropathy. (17227338)
2007
29
Effect of quinapril or losartan alone and in combination on left ventricular systolic and diastolic functions in asymptomatic patients with diabetic autonomic neuropathy. (16389160)
2006
30
Severe orthostatic hypotension with diabetic autonomic neuropathy successfully treated with a beta(1)-blocker: a case report. (16810280)
2006
31
Ergotamine use in severe diabetic autonomic neuropathy. (16681568)
2006
32
Acute dysautonomia: a rare manifestation of diabetic autonomic neuropathy masquerading as pheochromocytoma. (16279988)
2005
33
Images in clinical medicine. Gastric dilatation secondary to diabetic autonomic neuropathy. (16371635)
2005
34
Diabetic autonomic neuropathy: evidence for apoptosis in situ in the rat. (15198656)
2004
35
Severe and disabling diabetic autonomic neuropathy: a case report. (15120708)
2004
36
Pupillography refines the diagnosis of diabetic autonomic neuropathy. (15240199)
2004
37
Diabetic autonomic neuropathy. (15088257)
2003
38
Use of heart rate reserve and rating of perceived exertion to prescribe exercise intensity in diabetic autonomic neuropathy. (12663561)
2003
39
Diabetic autonomic neuropathy: importance of its early detection for improving morbidity and mortality. (12879940)
2003
40
Diagnosis of diabetic autonomic neuropathy: a multivariate approach. (12864779)
2003
41
Diabetic autonomic neuropathy is associated with an increased incidence of strokes. (14614967)
2003
42
Diabetic autonomic neuropathy. (12716821)
2003
43
Non-obese diabetic mice rapidly develop dramatic sympathetic neuritic dystrophy: a new experimental model of diabetic autonomic neuropathy. (14578206)
2003
44
Comparative neuropathology and diabetic autonomic neuropathy. (14578168)
2003
45
The effectiveness of treatments of diabetic autonomic neuropathy is not the same in autonomic nerves supplying different organs. (12502507)
2003
46
Does diabetic autonomic neuropathy influence the clinical manifestations of reflux esophagitis? (14604253)
2003
47
Diagnosis and management of diabetic autonomic neuropathy. (14606343)
2003
48
Analysis of the Zucker Diabetic Fatty (ZDF) type 2 diabetic rat model suggests a neurotrophic role for insulin/IGF-I in diabetic autonomic neuropathy. (12819007)
2003
49
Resolution of diabetic autonomic neuropathy. (12151692)
2002
50
Neuropathology and pathogenesis of diabetic autonomic neuropathy. (12198813)
2002

Variations for Diabetic Autonomic Neuropathy

About this section

Expression for genes affiliated with Diabetic Autonomic Neuropathy

About this section
Search GEO for disease gene expression data for Diabetic Autonomic Neuropathy.

Pathways for genes affiliated with Diabetic Autonomic Neuropathy

About this section

Pathways related to Diabetic Autonomic Neuropathy according to GeneCards Suite gene sharing:

idSuper pathwaysScoreTop Affiliating Genes
19.8EPO, INS
2
Show member pathways
9.4NGF, NTF3
3
Show member pathways
9.4NGF, NTF3
49.1EPO, INS, NGF

GO Terms for genes affiliated with Diabetic Autonomic Neuropathy

About this section

Cellular components related to Diabetic Autonomic Neuropathy according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1extracellular regionGO:00055768.1AOC1, DBH, EPO, INS, NGF, NTF3
2extracellular spaceGO:00056158.1AKR1B1, AOC1, DBH, EPO, INS

Biological processes related to Diabetic Autonomic Neuropathy according to GeneCards Suite gene sharing:

(show all 7)
idNameGO IDScoreTop Affiliating Genes
1acute-phase responseGO:000695310.4EPO, INS
2activation of protein kinase B activityGO:003214810.4INS, NTF3
3positive regulation of DNA replicationGO:004574010.2EPO, INS
4neuron projection morphogenesisGO:004881210.0NGF, NTF3
5positive regulation of Ras protein signal transductionGO:00465799.9EPO, NGF
6cell-cell signalingGO:00072679.7INS, NGF, NTF3
7regulation of neuron differentiationGO:00456649.4NGF, NTF3

Molecular functions related to Diabetic Autonomic Neuropathy according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1copper ion bindingGO:00055079.1AOC1, DBH

Sources for Diabetic Autonomic Neuropathy

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet